| Pharmaceutical Information |
| Drug Name |
Trifluoperazine |
| Drug ID |
BADD_D02281 |
| Description |
A phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic. |
| Indications and Usage |
For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation. |
| Marketing Status |
approved; investigational |
| ATC Code |
N05AB06 |
| DrugBank ID |
DB00831
|
| KEGG ID |
D01448; D08636
|
| MeSH ID |
D014268
|
| PubChem ID |
5566
|
| TTD Drug ID |
D0R4OM
|
| NDC Product Code |
Not Available |
| UNII |
214IZI85K3
|
| Synonyms |
Trifluoperazine | Trifluperazine | Trifluoroperazine | Eskazine | Flupazine | Terfluzine | Trifluoperazine Hydrochloride | Trifluoperazine HCL | Triftazin | Apo-Trifluoperazine | Apo Trifluoperazine | ApoTrifluoperazine | Stelazine |
|
| Chemical Information |
| Molecular Formula |
C21H24F3N3S |
| CAS Registry Number |
117-89-5 |
| SMILES |
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
